Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
More serious problems like gastroparesis, delayed gastric emptying, or chronic digestive problems require caution
Important considerations for ongoing management: Your prescriber may need to adjust your dose, switch to an alternative GLP-1 medicine, or investigate other potential causes of digestive symptoms
This is why our programs focus on finding the right dose of a single medication that supports your goals without compromising your quality of life
Do you require any sort of membership or subscription?
Methodology Primary Research: Interviews with endocrinologists, clinical pharmacologists, and pharmaceutical market experts
Wegovy is the brand name for a once a week, injectable version of semaglutide produced by Novo Nordisk for the treatment of obesity
